Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 24/10/20021 min de lecture
Determination of Regulatory Review Period for Purposes of Patent Extension; MIFEPREX; Amendment
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending a previous determination of the regulatory review period for MIFEPREX that appeared in the Federal Register of January 25, 2002 (67 FR 3724). The agency is taking this action in response to received comments. FDA is publishing notice of that amendment as required by law.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →